You just read:

Statement from FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., and Jeff Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health, on the agency's continued efforts to protect women's health and enhance safety information available to patients considering breast implants

News provided by

U.S. Food and Drug Administration

Oct 23, 2019, 09:59 ET